Retour sur lavenir.net
   RECTICEL 12.160 € (+1,16 %)     UCB 242.100 € (-0,74 %)     ACKERMANS V.HAAREN 269.400 € (+0,30 %)     D'IETEREN GROUP 175.200 € (+1,62 %)     BELYSSE GROUP 0.500 € (+4,17 %)     LOTUS BAKERIES 10 940.000 € (+1,30 %)     SYENSQO 70.250 € (+1,37 %)     AB INBEV 72.720 € (+1,73 %)     ELIA GROUP 139.800 € (+1,60 %)     TINC 11.360 € (+1,97 %)     BREDERODE 103.400 € (+0,39 %)     SOLVAY 26.140 € (+0,62 %)     MONTEA 68.800 € (+1,33 %)     WDP 22.520 € (+1,90 %)     COLRUYT 38.160 € (+0,58 %)     XIOR 27.975 € (+0,09 %)     UMICORE 20.160 € (+1,00 %)     ARGENX SE 757.800 € (-0,32 %)     GBL 77.900 € (+0,91 %)     ONWARD MEDICAL 2.490 € (+0,20 %)     RETAIL ESTATES 68.600 € (+1,48 %)     SOFINA 233.600 € (+1,92 %)     KBC ANCORA 87.200 € (0,00 %)     TUBIZE-FIN 210.400 € (+0,67 %)     EVS 27.100 € (+0,74 %)     CMB.TECH 13.460 € (-1,17 %)     SIPEF 94.500 € (+2,27 %)     AEDIFICA 70.250 € (+0,50 %)     AGEAS 71.800 € (+1,41 %)     PROXIMUS 6.115 € (+0,91 %)     FAGRON 23.700 € (-0,63 %)     GIMV 44.900 € (+0,79 %)     KBC 122.650 € (+0,25 %)     BPOST 1.566 € (-0,25 %)     TESSENDERLO 20.950 € (+2,20 %)     MELEXIS 73.875 € (+2,60 %)     VIOHALCO 17.840 € (+3,60 %)     ONTEX GROUP 2.255 € (+2,04 %)     NYXOAH 1.358 € (-1,88 %)     BEKAERT 41.600 € (+0,85 %)     VASTNED 29.450 € (+0,51 %)     VGP 82.500 € (+1,73 %)     AZELIS GROUP 10.520 € (+0,10 %)     BARCO 8.025 € (+2,95 %)     CENERGY 21.700 € (+2,07 %)     TITAN S.A. 51.200 € (+4,92 %)     IBA 16.620 € (-0,72 %)     SHURGARD 25.500 € (+1,19 %)     DEME GROUP 169.600 € (+0,47 %)     CARE PROPERTY INV. 12.720 € (+0,63 %)     CELYAD ONCOLOGY 0.290 € (+5,07 %)     KINEPOLIS GROUP 38.700 € (+0,13 %)     HOME INVEST BE. 19.840 € (+1,95 %)     DECEUNINCK 2.190 € (+0,69 %)     JENSEN-GROUP 85.200 € (+1,19 %)     NEXTENSA 45.800 € (+0,22 %)     ACCENTIS 0.026 € (0,00 %)     BIOTALYS 2.985 € (+0,17 %)     EKOPAK 3.750 € (+1,08 %)     VAN DE VELDE 30.100 € (+1,69 %)  
   EXOSENS 61.400 € (+1,66 %)     CVC CAPITAL 14.300 € (-0,83 %)     CEGEDIM 10.120 € (+0,20 %)     FDJ UNITED 22.790 € (-0,13 %)     CARREFOUR 16.695 € (+0,91 %)     LEGRAND 137.350 € (+0,07 %)     TOTALENERGIES 74.150 € (+1,84 %)     PUBLICIS GROUPE SA 86.400 € (+0,33 %)     ASML HOLDING 1 584.600 € (-0,55 %)     KPN KON 4.240 € (-0,16 %)     HEINEKEN 77.700 € (+1,01 %)     NOS, SGPS 4.914 € (+0,20 %)     CTT CORREIOS PORT 6.210 € (+3,93 %)     PROSUS 36.895 € (-4,16 %)     STIF 52.900 € (+0,28 %)     L'OREAL 380.500 € (+0,46 %)     GALP ENERGIA-NOM 20.160 € (+1,23 %)     VINCI 119.350 € (+0,76 %)     NEXITY 7.480 € (-2,03 %)     PULLUP ENTERTAIN 8.660 € (-0,35 %)     ADYEN 820.900 € (+0,04 %)     KERING 250.250 € (-0,28 %)     EIFFAGE 122.900 € (+0,16 %)     AIR FRANCE -KLM 11.690 € (-2,79 %)     SANOFI 77.080 € (+0,43 %)     RELX 28.900 € (0,00 %)     IMCD 88.820 € (+0,98 %)     WOLTERS KLUWER 59.880 € (-0,20 %)     AMUNDI 88.200 € (-0,84 %)     FORVIA 8.612 € (-2,40 %)     RENAULT 26.390 € (+1,97 %)     ASR NEDERLAND 70.600 € (+1,38 %)     ENGIE 27.660 € (+2,33 %)     LVMH 475.850 € (-0,56 %)     AIR LIQUIDE 176.820 € (+0,17 %)     AIRBUS 207.650 € (+6,71 %)     DSM FIRMENICH AG 85.280 € (+1,55 %)     BNP PARIBAS ACT.A 106.740 € (+1,50 %)     TELEPERFORMANCE 54.720 € (+2,63 %)     AKZO NOBEL 58.140 € (+1,71 %)     SCHNEIDER ELECTRIC 270.000 € (+0,45 %)     STMICROELECTRONICS 58.150 € (+1,57 %)     BOLLORE 3.906 € (+0,67 %)     CAPGEMINI 88.600 € (-1,58 %)     APERAM 47.580 € (+1,41 %)     LUMIBIRD 27.750 € (-1,25 %)     HERMES INTL 1 678.000 € (-0,18 %)     ASM INTERNATIONAL 893.000 € (-1,06 %)     AEGON 8.052 € (+0,40 %)     S.E.B. 49.200 € (+1,78 %)     EDENRED 27.060 € (+1,23 %)     ARCELORMITTAL SA 58.420 € (+0,97 %)     Vusion 125.100 € (+0,08 %)     CORBION 19.220 € (-0,98 %)     AHOLD DEL 35.780 € (+0,42 %)     LECTRA 18.440 € (+0,88 %)     ARCADIS 35.340 € (+2,79 %)     EURAZEO 43.790 € (+0,21 %)     CREDIT AGRICOLE 18.230 € (+0,69 %)     VERALLIA 19.370 € (+1,41 %)  
News Réglementées
13/07/2026 12:59

EQS-Adhoc: BRAIN Biotech AG signs new Revolving Credit Facility with MP Beteiligungs-GmbH

EQS-Ad-hoc: BRAIN Biotech AG / Key word(s): Capital measures / Significant loan agreement
BRAIN Biotech AG signs new Revolving Credit Facility with MP Beteiligungs-GmbH

13-Jul-2026 / 12:59 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.


NOT FOR DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR DISSEMINATION WOULD BE UNLAWFUL. OTHER RESTRICTIONS APPLY. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.

 

BRAIN Biotech AG signs new Revolving Credit Facility with MP Beteiligungs-GmbH

Zwingenberg, Germany, July 13, 2026 – BRAIN Biotech AG (ISIN DE0005203947; “BRAIN” or “Company”) has entered into an agreement with MP Beteiligungs-GmbH (MPBG) for a new revolving credit line of €9.0 million. The term ends on December 31, 2028. Interest on the loan amount drawn will be charged at a variable market-conform interest rate of 6-Month-Forward-Euribor plus 233 basis points per annum. This revolving credit line is intended for general corporate financing purposes and scheduled debt services.

 

Notifying person:

Martina Schuster

BRAIN Biotech AG

– Investor Relations –

Darmstädter Str. 34-36

64673 Zwingenberg

Deutschland
 

www.brain-biotech.com

Investor Relations Office

Tel.: +49-(0)-6251-9331-0

Fax: +49-(0)-6251-9331-11

E-Mail: ir@brain-biotech.com


IMPORTANT NOTICE

This announcement may not be published, distributed or released in the United States of America (including its territories and possessions, any state of the United States of America and the District of Columbia), Australia, Canada, Japan or any other jurisdiction in which the publication, distribution or release would be unlawful. This announcement does not constitute an offer of securities of the company for sale or a solicitation of an offer to purchase securities of the company. There will be no public offer of securities of the Company.



End of Inside Information

13-Jul-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News


Language:English
Company:BRAIN Biotech AG
Darmstädter Straße 34-36
64673 Zwingenberg
Germany
Phone:+49 (0) 62 51 / 9331-0
Fax:+49 (0) 62 51 / 9331-11
E-mail:ir@brain-biotech.com
Internet:www.brain-biotech.com
ISIN:DE0005203947
WKN:520394
Listed:Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate BSX
EQS News ID:2364832

 
End of AnnouncementEQS News Service

2364832  13-Jul-2026 CET/CEST

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière